Taysha Gene Therapies Inc (TSHA)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-04-10 | Dr. Sukumar NagendranPresident, Head of Research & Development and Director | -180.98k | 807.17k | Automatic Disposition | 4.46 | 34.23k | -84.10% |
| 2026-04-10 | Dr. Sukumar NagendranPresident, Head of Research & Development and Director | -19.02k | 52.31k | Derivative Exercise and Sale | 1.71 - 4.46 | 34.23k | - |
| 2026-02-04 | Mr. Kamran AlamCFO & Corporate Secretary | -1.66k | 7.48k | 売り | 4.52 | 1.44M | -0.11% |
| 2026-01-23 | Mr. Kamran AlamCFO & Corporate Secretary | -102.82k | 485.04k | 売り | 4.61 - 4.75 | 1.44M | -6.65% |
| 2026-01-23 | Mr. Sean P. NolanCEO & Chairman | -178.10k | 840.20k | 売り | 4.61 - 4.75 | 638.54k | -21.81% |
| 2026-01-23 | Dr. Sukumar NagendranPresident, Head of Research & Development and Director | -116.05k | 547.47k | 売り | 4.61 - 4.75 | 215.21k | -35.03% |
| 2026-01-12 | Dr. Sukumar NagendranPresident, Head of Research & Development and Director | -200.00k | 712.56k | Derivative Exercise and Sale | 0.70 - 4.71 | 331.26k | - |
| 2025-11-28 | Dr. Sukumar NagendranPresident, Head of Research & Development and Director | -370.17k | 1.13M | Derivative Exercise and Sale | 0.70 - 4.75 | 34.23k | - |
| 2025-09-10 | Dr. Sukumar NagendranPresident, Head of Research & Development and Director | -41.15k | 104.15k | Derivative Exercise and Sale | 0.70 - 3.23 | 34.23k | - |
| 2025-09-10 | Dr. Sukumar NagendranPresident, Head of Research & Development and Director | -158.85k | 513.09k | Automatic Disposition | 3.23 | 34.23k | -82.27% |
| 2025-08-21 | Mr. Kamran AlamCFO & Corporate Secretary | -54.49k | 155.30k | 売り | 2.85 | 1.19M | -4.39% |
| 2025-08-21 | Dr. Sukumar NagendranPresident, Head of Research & Development and Director | -57.05k | 162.60k | 売り | 2.85 | 193.08k | -22.81% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。